Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
136,8 EUR | -0,09% | +1,18% | -2,65% |
08/06 | Topadvocatenkantoren in Amerikaanse opioïde rechtszaken krijgen honderden miljoenen aan vergoedingen | RE |
07/06 | Rapport Therapeutics, gesteund door J&J, debuteert bijna 6% hoger | RE |
Omzet 2024 * | 88,79 mld. 82,49 mld. | Omzet 2025 * | 92,1 mld. 85,58 mld. | Marktkapitalisatie | 354 mld. 329 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 3,99 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 3,84 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | 131.900 |
Dividendrendement 2024 * |
3,28% | Dividendrendement 2025 * |
3,43% | Vrij verhandelbaar | 77,08% |
Recentste transcriptie over Johnson & Johnson
1 dag | -0,09% | ||
1 week | +1,18% | ||
Lopende maand | +1,18% | ||
1 maand | -1,45% | ||
3 maanden | -5,99% | ||
6 maanden | -4,41% | ||
Lopend jaar | -2,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 01-01-89 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 01-01-98 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 05-11-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 25-04-19 |
D. Davis
BRD | Director/Board Member | 72 | 19-06-14 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 22-10-09 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
07-06-24 | 136,9 | +1,62% | 0 |
10-06-24 | 136 | -0,63% | 39 |
07-06-24 | 136,9 | +1,62% | 0 |
06-06-24 | 134,7 | -0,40% | 0 |
05-06-24 | 135,2 | +0,27% | 0 |
slotkoers Borsa Italiana, 07 juni 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+48,39% | 765 mld. | |
+20,61% | 331 mld. | |
+10,00% | 299 mld. | |
+18,87% | 248 mld. | |
-1,96% | 219 mld. | |
+11,11% | 216 mld. | |
+5,80% | 164 mld. | |
-2,50% | 162 mld. | |
+0,57% | 123 mld. |